-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下:我們將百勝中國12個月的目標價從60美元下調至52美元,這意味著2026年的本益比為18.2倍(與三年平均持平)。我們認為,該公司的前景基本面正在改善,並且比近年來更具可預測性。我們歡迎百勝中國採取的策略性舉措,這些舉措旨在使其成為一家資本效率更高、股東回報更優的公司,但我們仍然對長期獲利能力的提升感到擔憂。我們預計,百勝中國營收成長將受益於門市網路的持續擴張,尤其是在服務不足的低線城市,以及產品創新和外送服務的日益普及。 2026年第一季度,外送分別佔必勝客和肯德基銷售額的約51%和55%。然而,我們認為,不斷上漲的配送成本和積極向低線城市擴張可能會導致其利潤率相比現有的一線城市策略更為溫和。
Related Articles
BNP Paribas Adjusts Price Target on Ingersoll Rand to $82 From $94
Ingersoll Rand (IR) has an average rating of overweight and mean price target of $96.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $77.89, Change: $+0.43, Percent Change: +0.56%
Mizuho Adjusts Price Target on Humana to $290 From $258
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%
Jefferies Adjusts Price Target on Humana to $290 From $235
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%